Trask Anna's Form 4 filing
Decibel Therapeutics, Inc. (DBTX) · filed Jan 4, 2022
- Accession no.
- 0000899243-22-000490
- Filed
- Jan 4, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.90K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trask AnnaCIK 0001842132 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | SSaleDisposed | −1 | $5.04 | −$5.04 | 2,241 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −377 | $5.03 | −$1,896.31 | 1,864 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
CHIEF PEOPLE, COMMUNITY & CULTURE OFFICER